Global Tafenoquine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Tafenoquine market size was valued at US$ million in 2023. With growing demand in downstream market, the Tafenoquine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tafenoquine market. Tafenoquine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tafenoquine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tafenoquine market.
Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
Key Features:
The report on Tafenoquine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tafenoquine market. It may include historical data, market segmentation by Type (e.g., Powder, Pills), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tafenoquine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tafenoquine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tafenoquine industry. This include advancements in Tafenoquine technology, Tafenoquine new entrants, Tafenoquine new investment, and other innovations that are shaping the future of Tafenoquine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tafenoquine market. It includes factors influencing customer ' purchasing decisions, preferences for Tafenoquine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tafenoquine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tafenoquine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tafenoquine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tafenoquine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tafenoquine market.
Market Segmentation:
Tafenoquine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Tafenoquine market?
What factors are driving Tafenoquine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafenoquine market opportunities vary by end market size?
How does Tafenoquine break out type, application?
According to our LPI (LP Information) latest study, the global Tafenoquine market size was valued at US$ million in 2023. With growing demand in downstream market, the Tafenoquine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tafenoquine market. Tafenoquine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tafenoquine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tafenoquine market.
Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
Key Features:
The report on Tafenoquine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tafenoquine market. It may include historical data, market segmentation by Type (e.g., Powder, Pills), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tafenoquine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tafenoquine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tafenoquine industry. This include advancements in Tafenoquine technology, Tafenoquine new entrants, Tafenoquine new investment, and other innovations that are shaping the future of Tafenoquine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tafenoquine market. It includes factors influencing customer ' purchasing decisions, preferences for Tafenoquine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tafenoquine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tafenoquine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tafenoquine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tafenoquine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tafenoquine market.
Market Segmentation:
Tafenoquine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Powder
- Pills
- Radical Cure of P.vivax
- P. falciparum Treatment
- Prevention of Malaria Relapse
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline Pharmaceuticals (GSK)
- J & K Scientific LTD
- BOC Sciences
- WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- Pharmacodia (Beijing) Co.,Ltd
- Amadis Chemical Company Limited
- Merck
What is the 10-year outlook for the global Tafenoquine market?
What factors are driving Tafenoquine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafenoquine market opportunities vary by end market size?
How does Tafenoquine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafenoquine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tafenoquine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tafenoquine by Country/Region, 2019, 2023 & 2030
2.2 Tafenoquine Segment by Type
2.2.1 Powder
2.2.2 Pills
2.3 Tafenoquine Sales by Type
2.3.1 Global Tafenoquine Sales Market Share by Type (2019-2024)
2.3.2 Global Tafenoquine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tafenoquine Sale Price by Type (2019-2024)
2.4 Tafenoquine Segment by Application
2.4.1 Radical Cure of P.vivax
2.4.2 P. falciparum Treatment
2.4.3 Prevention of Malaria Relapse
2.5 Tafenoquine Sales by Application
2.5.1 Global Tafenoquine Sale Market Share by Application (2019-2024)
2.5.2 Global Tafenoquine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tafenoquine Sale Price by Application (2019-2024)
3 GLOBAL TAFENOQUINE BY COMPANY
3.1 Global Tafenoquine Breakdown Data by Company
3.1.1 Global Tafenoquine Annual Sales by Company (2019-2024)
3.1.2 Global Tafenoquine Sales Market Share by Company (2019-2024)
3.2 Global Tafenoquine Annual Revenue by Company (2019-2024)
3.2.1 Global Tafenoquine Revenue by Company (2019-2024)
3.2.2 Global Tafenoquine Revenue Market Share by Company (2019-2024)
3.3 Global Tafenoquine Sale Price by Company
3.4 Key Manufacturers Tafenoquine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafenoquine Product Location Distribution
3.4.2 Players Tafenoquine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TAFENOQUINE BY GEOGRAPHIC REGION
4.1 World Historic Tafenoquine Market Size by Geographic Region (2019-2024)
4.1.1 Global Tafenoquine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tafenoquine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tafenoquine Market Size by Country/Region (2019-2024)
4.2.1 Global Tafenoquine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tafenoquine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tafenoquine Sales Growth
4.4 APAC Tafenoquine Sales Growth
4.5 Europe Tafenoquine Sales Growth
4.6 Middle East & Africa Tafenoquine Sales Growth
5 AMERICAS
5.1 Americas Tafenoquine Sales by Country
5.1.1 Americas Tafenoquine Sales by Country (2019-2024)
5.1.2 Americas Tafenoquine Revenue by Country (2019-2024)
5.2 Americas Tafenoquine Sales by Type
5.3 Americas Tafenoquine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafenoquine Sales by Region
6.1.1 APAC Tafenoquine Sales by Region (2019-2024)
6.1.2 APAC Tafenoquine Revenue by Region (2019-2024)
6.2 APAC Tafenoquine Sales by Type
6.3 APAC Tafenoquine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafenoquine by Country
7.1.1 Europe Tafenoquine Sales by Country (2019-2024)
7.1.2 Europe Tafenoquine Revenue by Country (2019-2024)
7.2 Europe Tafenoquine Sales by Type
7.3 Europe Tafenoquine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafenoquine by Country
8.1.1 Middle East & Africa Tafenoquine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tafenoquine Revenue by Country (2019-2024)
8.2 Middle East & Africa Tafenoquine Sales by Type
8.3 Middle East & Africa Tafenoquine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafenoquine
10.3 Manufacturing Process Analysis of Tafenoquine
10.4 Industry Chain Structure of Tafenoquine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafenoquine Distributors
11.3 Tafenoquine Customer
12 WORLD FORECAST REVIEW FOR TAFENOQUINE BY GEOGRAPHIC REGION
12.1 Global Tafenoquine Market Size Forecast by Region
12.1.1 Global Tafenoquine Forecast by Region (2025-2030)
12.1.2 Global Tafenoquine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tafenoquine Forecast by Type
12.7 Global Tafenoquine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline Pharmaceuticals (GSK)
13.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
13.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Main Business Overview
13.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments
13.2 J & K Scientific LTD
13.2.1 J & K Scientific LTD Company Information
13.2.2 J & K Scientific LTD Tafenoquine Product Portfolios and Specifications
13.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 J & K Scientific LTD Main Business Overview
13.2.5 J & K Scientific LTD Latest Developments
13.3 BOC Sciences
13.3.1 BOC Sciences Company Information
13.3.2 BOC Sciences Tafenoquine Product Portfolios and Specifications
13.3.3 BOC Sciences Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 BOC Sciences Main Business Overview
13.3.5 BOC Sciences Latest Developments
13.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
13.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
13.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolios and Specifications
13.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Main Business Overview
13.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments
13.5 Pharmacodia (Beijing) Co.,Ltd
13.5.1 Pharmacodia (Beijing) Co.,Ltd Company Information
13.5.2 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolios and Specifications
13.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pharmacodia (Beijing) Co.,Ltd Main Business Overview
13.5.5 Pharmacodia (Beijing) Co.,Ltd Latest Developments
13.6 Amadis Chemical Company Limited
13.6.1 Amadis Chemical Company Limited Company Information
13.6.2 Amadis Chemical Company Limited Tafenoquine Product Portfolios and Specifications
13.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amadis Chemical Company Limited Main Business Overview
13.6.5 Amadis Chemical Company Limited Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Tafenoquine Product Portfolios and Specifications
13.7.3 Merck Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafenoquine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Tafenoquine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Tafenoquine by Country/Region, 2019, 2023 & 2030
2.2 Tafenoquine Segment by Type
2.2.1 Powder
2.2.2 Pills
2.3 Tafenoquine Sales by Type
2.3.1 Global Tafenoquine Sales Market Share by Type (2019-2024)
2.3.2 Global Tafenoquine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Tafenoquine Sale Price by Type (2019-2024)
2.4 Tafenoquine Segment by Application
2.4.1 Radical Cure of P.vivax
2.4.2 P. falciparum Treatment
2.4.3 Prevention of Malaria Relapse
2.5 Tafenoquine Sales by Application
2.5.1 Global Tafenoquine Sale Market Share by Application (2019-2024)
2.5.2 Global Tafenoquine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Tafenoquine Sale Price by Application (2019-2024)
3 GLOBAL TAFENOQUINE BY COMPANY
3.1 Global Tafenoquine Breakdown Data by Company
3.1.1 Global Tafenoquine Annual Sales by Company (2019-2024)
3.1.2 Global Tafenoquine Sales Market Share by Company (2019-2024)
3.2 Global Tafenoquine Annual Revenue by Company (2019-2024)
3.2.1 Global Tafenoquine Revenue by Company (2019-2024)
3.2.2 Global Tafenoquine Revenue Market Share by Company (2019-2024)
3.3 Global Tafenoquine Sale Price by Company
3.4 Key Manufacturers Tafenoquine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafenoquine Product Location Distribution
3.4.2 Players Tafenoquine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TAFENOQUINE BY GEOGRAPHIC REGION
4.1 World Historic Tafenoquine Market Size by Geographic Region (2019-2024)
4.1.1 Global Tafenoquine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Tafenoquine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Tafenoquine Market Size by Country/Region (2019-2024)
4.2.1 Global Tafenoquine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Tafenoquine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Tafenoquine Sales Growth
4.4 APAC Tafenoquine Sales Growth
4.5 Europe Tafenoquine Sales Growth
4.6 Middle East & Africa Tafenoquine Sales Growth
5 AMERICAS
5.1 Americas Tafenoquine Sales by Country
5.1.1 Americas Tafenoquine Sales by Country (2019-2024)
5.1.2 Americas Tafenoquine Revenue by Country (2019-2024)
5.2 Americas Tafenoquine Sales by Type
5.3 Americas Tafenoquine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafenoquine Sales by Region
6.1.1 APAC Tafenoquine Sales by Region (2019-2024)
6.1.2 APAC Tafenoquine Revenue by Region (2019-2024)
6.2 APAC Tafenoquine Sales by Type
6.3 APAC Tafenoquine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafenoquine by Country
7.1.1 Europe Tafenoquine Sales by Country (2019-2024)
7.1.2 Europe Tafenoquine Revenue by Country (2019-2024)
7.2 Europe Tafenoquine Sales by Type
7.3 Europe Tafenoquine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafenoquine by Country
8.1.1 Middle East & Africa Tafenoquine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Tafenoquine Revenue by Country (2019-2024)
8.2 Middle East & Africa Tafenoquine Sales by Type
8.3 Middle East & Africa Tafenoquine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafenoquine
10.3 Manufacturing Process Analysis of Tafenoquine
10.4 Industry Chain Structure of Tafenoquine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafenoquine Distributors
11.3 Tafenoquine Customer
12 WORLD FORECAST REVIEW FOR TAFENOQUINE BY GEOGRAPHIC REGION
12.1 Global Tafenoquine Market Size Forecast by Region
12.1.1 Global Tafenoquine Forecast by Region (2025-2030)
12.1.2 Global Tafenoquine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tafenoquine Forecast by Type
12.7 Global Tafenoquine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline Pharmaceuticals (GSK)
13.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
13.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Main Business Overview
13.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments
13.2 J & K Scientific LTD
13.2.1 J & K Scientific LTD Company Information
13.2.2 J & K Scientific LTD Tafenoquine Product Portfolios and Specifications
13.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 J & K Scientific LTD Main Business Overview
13.2.5 J & K Scientific LTD Latest Developments
13.3 BOC Sciences
13.3.1 BOC Sciences Company Information
13.3.2 BOC Sciences Tafenoquine Product Portfolios and Specifications
13.3.3 BOC Sciences Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 BOC Sciences Main Business Overview
13.3.5 BOC Sciences Latest Developments
13.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
13.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
13.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolios and Specifications
13.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Main Business Overview
13.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments
13.5 Pharmacodia (Beijing) Co.,Ltd
13.5.1 Pharmacodia (Beijing) Co.,Ltd Company Information
13.5.2 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolios and Specifications
13.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pharmacodia (Beijing) Co.,Ltd Main Business Overview
13.5.5 Pharmacodia (Beijing) Co.,Ltd Latest Developments
13.6 Amadis Chemical Company Limited
13.6.1 Amadis Chemical Company Limited Company Information
13.6.2 Amadis Chemical Company Limited Tafenoquine Product Portfolios and Specifications
13.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amadis Chemical Company Limited Main Business Overview
13.6.5 Amadis Chemical Company Limited Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Tafenoquine Product Portfolios and Specifications
13.7.3 Merck Tafenoquine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tafenoquine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Tafenoquine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Pills
Table 5. Global Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 6. Global Tafenoquine Sales Market Share by Type (2019-2024)
Table 7. Global Tafenoquine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Tafenoquine Revenue Market Share by Type (2019-2024)
Table 9. Global Tafenoquine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 11. Global Tafenoquine Sales Market Share by Application (2019-2024)
Table 12. Global Tafenoquine Revenue by Application (2019-2024)
Table 13. Global Tafenoquine Revenue Market Share by Application (2019-2024)
Table 14. Global Tafenoquine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Tafenoquine Sales by Company (2019-2024) & (K Units)
Table 16. Global Tafenoquine Sales Market Share by Company (2019-2024)
Table 17. Global Tafenoquine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Tafenoquine Revenue Market Share by Company (2019-2024)
Table 19. Global Tafenoquine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Tafenoquine Producing Area Distribution and Sales Area
Table 21. Players Tafenoquine Products Offered
Table 22. Tafenoquine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tafenoquine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Tafenoquine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Tafenoquine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Tafenoquine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Tafenoquine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Tafenoquine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Tafenoquine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Tafenoquine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Tafenoquine Sales Market Share by Country (2019-2024)
Table 35. Americas Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Tafenoquine Revenue Market Share by Country (2019-2024)
Table 37. Americas Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Tafenoquine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Tafenoquine Sales Market Share by Region (2019-2024)
Table 41. APAC Tafenoquine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Tafenoquine Revenue Market Share by Region (2019-2024)
Table 43. APAC Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Tafenoquine Sales Market Share by Country (2019-2024)
Table 47. Europe Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Tafenoquine Revenue Market Share by Country (2019-2024)
Table 49. Europe Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Tafenoquine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Tafenoquine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tafenoquine
Table 58. Key Market Challenges & Risks of Tafenoquine
Table 59. Key Industry Trends of Tafenoquine
Table 60. Tafenoquine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tafenoquine Distributors List
Table 63. Tafenoquine Customer List
Table 64. Global Tafenoquine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Tafenoquine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Tafenoquine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Tafenoquine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Tafenoquine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Tafenoquine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Tafenoquine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Tafenoquine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolios and Specifications
Table 80. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. GlaxoSmithKline Pharmaceuticals (GSK) Main Business
Table 82. GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments
Table 83. J & K Scientific LTD Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 84. J & K Scientific LTD Tafenoquine Product Portfolios and Specifications
Table 85. J & K Scientific LTD Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. J & K Scientific LTD Main Business
Table 87. J & K Scientific LTD Latest Developments
Table 88. BOC Sciences Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 89. BOC Sciences Tafenoquine Product Portfolios and Specifications
Table 90. BOC Sciences Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. BOC Sciences Main Business
Table 92. BOC Sciences Latest Developments
Table 93. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 94. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolios and Specifications
Table 95. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Main Business
Table 97. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments
Table 98. Pharmacodia (Beijing) Co.,Ltd Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 99. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolios and Specifications
Table 100. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Pharmacodia (Beijing) Co.,Ltd Main Business
Table 102. Pharmacodia (Beijing) Co.,Ltd Latest Developments
Table 103. Amadis Chemical Company Limited Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 104. Amadis Chemical Company Limited Tafenoquine Product Portfolios and Specifications
Table 105. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Amadis Chemical Company Limited Main Business
Table 107. Amadis Chemical Company Limited Latest Developments
Table 108. Merck Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck Tafenoquine Product Portfolios and Specifications
Table 110. Merck Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Merck Main Business
Table 112. Merck Latest Developments
Table 1. Tafenoquine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Tafenoquine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Pills
Table 5. Global Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 6. Global Tafenoquine Sales Market Share by Type (2019-2024)
Table 7. Global Tafenoquine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Tafenoquine Revenue Market Share by Type (2019-2024)
Table 9. Global Tafenoquine Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 11. Global Tafenoquine Sales Market Share by Application (2019-2024)
Table 12. Global Tafenoquine Revenue by Application (2019-2024)
Table 13. Global Tafenoquine Revenue Market Share by Application (2019-2024)
Table 14. Global Tafenoquine Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Tafenoquine Sales by Company (2019-2024) & (K Units)
Table 16. Global Tafenoquine Sales Market Share by Company (2019-2024)
Table 17. Global Tafenoquine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Tafenoquine Revenue Market Share by Company (2019-2024)
Table 19. Global Tafenoquine Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Tafenoquine Producing Area Distribution and Sales Area
Table 21. Players Tafenoquine Products Offered
Table 22. Tafenoquine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tafenoquine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Tafenoquine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Tafenoquine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Tafenoquine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Tafenoquine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Tafenoquine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Tafenoquine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Tafenoquine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Tafenoquine Sales Market Share by Country (2019-2024)
Table 35. Americas Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Tafenoquine Revenue Market Share by Country (2019-2024)
Table 37. Americas Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Tafenoquine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Tafenoquine Sales Market Share by Region (2019-2024)
Table 41. APAC Tafenoquine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Tafenoquine Revenue Market Share by Region (2019-2024)
Table 43. APAC Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Tafenoquine Sales Market Share by Country (2019-2024)
Table 47. Europe Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Tafenoquine Revenue Market Share by Country (2019-2024)
Table 49. Europe Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Tafenoquine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Tafenoquine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Tafenoquine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Tafenoquine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Tafenoquine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Tafenoquine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Tafenoquine
Table 58. Key Market Challenges & Risks of Tafenoquine
Table 59. Key Industry Trends of Tafenoquine
Table 60. Tafenoquine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tafenoquine Distributors List
Table 63. Tafenoquine Customer List
Table 64. Global Tafenoquine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Tafenoquine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Tafenoquine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Tafenoquine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Tafenoquine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Tafenoquine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Tafenoquine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Tafenoquine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Tafenoquine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Tafenoquine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. GlaxoSmithKline Pharmaceuticals (GSK) Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolios and Specifications
Table 80. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. GlaxoSmithKline Pharmaceuticals (GSK) Main Business
Table 82. GlaxoSmithKline Pharmaceuticals (GSK) Latest Developments
Table 83. J & K Scientific LTD Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 84. J & K Scientific LTD Tafenoquine Product Portfolios and Specifications
Table 85. J & K Scientific LTD Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. J & K Scientific LTD Main Business
Table 87. J & K Scientific LTD Latest Developments
Table 88. BOC Sciences Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 89. BOC Sciences Tafenoquine Product Portfolios and Specifications
Table 90. BOC Sciences Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. BOC Sciences Main Business
Table 92. BOC Sciences Latest Developments
Table 93. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 94. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolios and Specifications
Table 95. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Main Business
Table 97. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Latest Developments
Table 98. Pharmacodia (Beijing) Co.,Ltd Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 99. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolios and Specifications
Table 100. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Pharmacodia (Beijing) Co.,Ltd Main Business
Table 102. Pharmacodia (Beijing) Co.,Ltd Latest Developments
Table 103. Amadis Chemical Company Limited Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 104. Amadis Chemical Company Limited Tafenoquine Product Portfolios and Specifications
Table 105. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Amadis Chemical Company Limited Main Business
Table 107. Amadis Chemical Company Limited Latest Developments
Table 108. Merck Basic Information, Tafenoquine Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck Tafenoquine Product Portfolios and Specifications
Table 110. Merck Tafenoquine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Merck Main Business
Table 112. Merck Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tafenoquine
Figure 2. Tafenoquine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tafenoquine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Tafenoquine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Tafenoquine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Pills
Figure 11. Global Tafenoquine Sales Market Share by Type in 2023
Figure 12. Global Tafenoquine Revenue Market Share by Type (2019-2024)
Figure 13. Tafenoquine Consumed in Radical Cure of P.vivax
Figure 14. Global Tafenoquine Market: Radical Cure of P.vivax (2019-2024) & (K Units)
Figure 15. Tafenoquine Consumed in P. falciparum Treatment
Figure 16. Global Tafenoquine Market: P. falciparum Treatment (2019-2024) & (K Units)
Figure 17. Tafenoquine Consumed in Prevention of Malaria Relapse
Figure 18. Global Tafenoquine Market: Prevention of Malaria Relapse (2019-2024) & (K Units)
Figure 19. Global Tafenoquine Sales Market Share by Application (2023)
Figure 20. Global Tafenoquine Revenue Market Share by Application in 2023
Figure 21. Tafenoquine Sales Market by Company in 2023 (K Units)
Figure 22. Global Tafenoquine Sales Market Share by Company in 2023
Figure 23. Tafenoquine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Tafenoquine Revenue Market Share by Company in 2023
Figure 25. Global Tafenoquine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Tafenoquine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Tafenoquine Sales 2019-2024 (K Units)
Figure 28. Americas Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Tafenoquine Sales 2019-2024 (K Units)
Figure 30. APAC Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Tafenoquine Sales 2019-2024 (K Units)
Figure 32. Europe Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Tafenoquine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Tafenoquine Sales Market Share by Country in 2023
Figure 36. Americas Tafenoquine Revenue Market Share by Country in 2023
Figure 37. Americas Tafenoquine Sales Market Share by Type (2019-2024)
Figure 38. Americas Tafenoquine Sales Market Share by Application (2019-2024)
Figure 39. United States Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Tafenoquine Sales Market Share by Region in 2023
Figure 44. APAC Tafenoquine Revenue Market Share by Regions in 2023
Figure 45. APAC Tafenoquine Sales Market Share by Type (2019-2024)
Figure 46. APAC Tafenoquine Sales Market Share by Application (2019-2024)
Figure 47. China Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Tafenoquine Sales Market Share by Country in 2023
Figure 55. Europe Tafenoquine Revenue Market Share by Country in 2023
Figure 56. Europe Tafenoquine Sales Market Share by Type (2019-2024)
Figure 57. Europe Tafenoquine Sales Market Share by Application (2019-2024)
Figure 58. Germany Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Tafenoquine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Tafenoquine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Tafenoquine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Tafenoquine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tafenoquine in 2023
Figure 73. Manufacturing Process Analysis of Tafenoquine
Figure 74. Industry Chain Structure of Tafenoquine
Figure 75. Channels of Distribution
Figure 76. Global Tafenoquine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Tafenoquine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Tafenoquine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Tafenoquine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Tafenoquine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Tafenoquine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Tafenoquine
Figure 2. Tafenoquine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tafenoquine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Tafenoquine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Tafenoquine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Pills
Figure 11. Global Tafenoquine Sales Market Share by Type in 2023
Figure 12. Global Tafenoquine Revenue Market Share by Type (2019-2024)
Figure 13. Tafenoquine Consumed in Radical Cure of P.vivax
Figure 14. Global Tafenoquine Market: Radical Cure of P.vivax (2019-2024) & (K Units)
Figure 15. Tafenoquine Consumed in P. falciparum Treatment
Figure 16. Global Tafenoquine Market: P. falciparum Treatment (2019-2024) & (K Units)
Figure 17. Tafenoquine Consumed in Prevention of Malaria Relapse
Figure 18. Global Tafenoquine Market: Prevention of Malaria Relapse (2019-2024) & (K Units)
Figure 19. Global Tafenoquine Sales Market Share by Application (2023)
Figure 20. Global Tafenoquine Revenue Market Share by Application in 2023
Figure 21. Tafenoquine Sales Market by Company in 2023 (K Units)
Figure 22. Global Tafenoquine Sales Market Share by Company in 2023
Figure 23. Tafenoquine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Tafenoquine Revenue Market Share by Company in 2023
Figure 25. Global Tafenoquine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Tafenoquine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Tafenoquine Sales 2019-2024 (K Units)
Figure 28. Americas Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Tafenoquine Sales 2019-2024 (K Units)
Figure 30. APAC Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Tafenoquine Sales 2019-2024 (K Units)
Figure 32. Europe Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Tafenoquine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Tafenoquine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Tafenoquine Sales Market Share by Country in 2023
Figure 36. Americas Tafenoquine Revenue Market Share by Country in 2023
Figure 37. Americas Tafenoquine Sales Market Share by Type (2019-2024)
Figure 38. Americas Tafenoquine Sales Market Share by Application (2019-2024)
Figure 39. United States Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Tafenoquine Sales Market Share by Region in 2023
Figure 44. APAC Tafenoquine Revenue Market Share by Regions in 2023
Figure 45. APAC Tafenoquine Sales Market Share by Type (2019-2024)
Figure 46. APAC Tafenoquine Sales Market Share by Application (2019-2024)
Figure 47. China Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Tafenoquine Sales Market Share by Country in 2023
Figure 55. Europe Tafenoquine Revenue Market Share by Country in 2023
Figure 56. Europe Tafenoquine Sales Market Share by Type (2019-2024)
Figure 57. Europe Tafenoquine Sales Market Share by Application (2019-2024)
Figure 58. Germany Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Tafenoquine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Tafenoquine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Tafenoquine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Tafenoquine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Tafenoquine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tafenoquine in 2023
Figure 73. Manufacturing Process Analysis of Tafenoquine
Figure 74. Industry Chain Structure of Tafenoquine
Figure 75. Channels of Distribution
Figure 76. Global Tafenoquine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Tafenoquine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Tafenoquine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Tafenoquine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Tafenoquine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Tafenoquine Revenue Market Share Forecast by Application (2025-2030)
